Aug 13, 2020
Akcea Announces New Pricing and Reimbursement of WAYLIVRA® (volanesorsen) in Germany
Jun 17, 2020
Akcea Therapeutics to Present at the BMO 2020 Prescriptions for Success Healthcare Conference
Jun 12, 2020
PTC Therapeutics Announces 2-year Data from Part 1 of SUNFISH and New Data from JEWELFISH Trials for Risdiplam in Patients with Spinal Muscular Atrophy
Jun 09, 2020
Akcea Appoints New Senior Vice President, Business Development and Corporate Strategy
Jun 05, 2020
Ionis Pharmaceuticals to present at upcoming virtual investor conferences
Jun 04, 2020
Cure SMA Announces New Funding For Network Of Prominent SMA Clinical Research And Treatment Centers
May 28, 2020
Ionis Pharmaceuticals to host 2020 virtual annual meeting of stockholders
May 27, 2020
BrainStorm Appoints Pharmaceutical Veteran Stacy R. Lindborg, Ph.D. as Executive Vice President, Head of Global Clinical Research
May 18, 2020
Akcea Announces Appointment of New Chief Financial Officer
May 07, 2020
Akcea Expands Leadership Team with Appointment of Carla Poulson as Senior Vice President and Chief Human Resources Officer
May 06, 2020
Ionis reports first quarter 2020 financial results and recent business achievements
May 05, 2020
Akcea Reports Financial Results and Highlights for First Quarter 2020
May 01, 2020
Ionis Pharmaceuticals to host 2020 virtual annual meeting of stockholders
Apr 30, 2020
PTC Therapeutics Reports First Quarter 2020 Financial Results and Provides a Corporate Update
Apr 28, 2020
Confirmatory Part 2 of FIREFISH Demonstrates Survival and Motor Milestones Not Seen in Natural History in Infants with Type 1 Spinal Muscular Atrophy
Apr 22, 2020
Ionis Pharmaceuticals to hold first quarter 2020 financial results webcast
Apr 20, 2020
Ionis and partner announce enrollment completion of global Phase 3 GENERATION HD1 study for Huntington's disease
Apr 17, 2020
Visiongain Report: The Gene Therapy Market is Projected to Grow at a CAGR of 32% in the First Half of the Forecast Period
Apr 14, 2020
n-Lorem Foundation receives $500,000 donation for providing experimental antisense medicines to treat patients with ultra-rare diseases
Apr 07, 2020
PTC Announces Regulatory Update on Risdiplam for Spinal Muscular Atrophy (SMA)